Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Red Deer
Clinical trial register · Canada

Clinical Trials in Red Deer, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6553 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:20 UTC
6553
Studies in scope
all four open statuses
3487
Recruiting now
open to new participants
880
Lead sponsors
across recruiting studies
Top sites
Toronto 2818 Montreal 1913 Vancouver 1187 Calgary 1068 Edmonton 1018
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Pfizer6 University of Calgary4 Ipsen3 Sun Pharmaceutical Industries, Inc.2 Merz Therapeutics GmbH2 Sanofi2 Novo Nordisk A/S2 Novartis Pharmaceuticals1 UCB Biopharma SRL1 University of Alberta1 AbCellera Biologics Inc.1 AbbVie1 Takeda1 AstraZeneca1 Alumis Inc1 Eli Lilly and Company1 Medicago1 Vedanta Biosciences, Inc.1 Boehringer Ingelheim1
Site location
Toronto2818 Montreal1913 Vancouver1187 Calgary1068 Edmonton1018 Ottawa884 London878 Hamilton811 Québec682 Halifax535 Winnipeg454 Sherbrooke264 Kingston254 Kelowna176 Brampton143 Surrey138 Victoria129 St. John's126 Barrie125 Saskatoon125 Chicoutimi100 Moncton92 Mississauga89 Greater Sudbury83 Regina82 Show all 248
All 248 locations
Target enrolment
to

Trials with a site in Red Deer

33 of 6553 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Edmonton, Red Deer, Vancouver, Moncton, Truro, London, Mississauga, North York
2026-10-26
Not yet open
Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis
NCT07312929Renal Dialysis, Renal Replacement Therapy, Renal Diseases, Quality Health Care
University of Alberta
Observational
7,500
Calgary, Edmonton, Fort McMurray, Grand Prairie, Lethbridge, Medicine Hat, Red Deer, St. Albert
2026-10-01
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Calgary, Edmonton, Red Deer, Kelowna, Sydney, Sarnia, Stouffville, Toronto
2026-08-24
Recruiting
UCB Biopharma SRL
Phase 3
320
Barrie, Calgary, Fredericton, London, Québec, Red Deer, Surrey
2025-11-14
Active, closed
Pfizer
Phase 2
128
Calgary, Edmonton, Red Deer, Newmarket, Ottawa, Toronto, Québec
2025-11-13
Recruiting
Pfizer
Phase 2
200
Edmonton, Red Deer, Mississauga, Niagara Falls, Ottawa, Montreal, Québec
2025-10-30
Recruiting
Eli Lilly and Company
Phase 3
1,000
Kelowna, Lévis, Oakville, Québec, Red Deer, Toronto
2025-09-30
Active, closed
Merz Therapeutics GmbH
Phase 3
997
Montreal, Red Deer
2025-08-21
Active, closed
Merz Therapeutics GmbH
Phase 3
808
Montreal, Red Deer
2025-08-21
Recruiting
Sun Pharmaceutical Industries, Inc.
Phase 3
355
Calgary, Edmonton, Red Deer, Kelowna, Surrey, Markham, Newmarket, Toronto
2025-08-05
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Calgary, Red Deer, Kelowna, New Westminster, North Vancouver, Penticton, Surrey, Moncton
2025-07-22
Active, closed
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
NCT07118891Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
AbCellera Biologics Inc.
Phase 1/2
136
Calgary, Red Deer, Vancouver, Toronto, Lévis, Montreal, Mount Royal, Québec
2025-06-23
Recruiting
AstraZeneca
Phase 3
15,100
Red Deer, Richmond, Vancouver, Victoria, Bridgewater, Halifax, Sydney, Brampton
2025-06-04
Recruiting
University of Calgary
Not applicable
1,055
Calgary, Edmonton, High River, Red Deer
2025-05-16
Recruiting
Pfizer
Phase 3
674
Calgary, Red Deer, Winnipeg, Barrie, Guelph, London, Markham, Newmarket
2025-04-01
Recruiting
Pfizer
Phase 3
723
Red Deer, Kelowna, Surrey, Halifax, Brampton, Sarnia, Lévis
2025-03-11
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Edmonton, Red Deer, Surrey, Ajax, Barrie, Coburg, Guelph, Hamilton
2025-01-08
Active, closed
Pfizer
Phase 3
636
Edmonton, Red Deer, London
2024-11-15
Active, closed
Ipsen
Phase 2
670
Calgary, Lévis, Québec, Red Deer, Sarnia
2024-10-10
Recruiting
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic
DrugTenecteplase
University of Calgary
Phase 3
4,000
Calgary, Medicine Hat, Red Deer, Edmonton, Kelowna, New Westminster, Vancouver, Brandon
2024-09-26
Active, closed
Takeda
Phase 3
2,099
Calgary, Edmonton, Red Deer, Surrey, Winnipeg, St. John's, Ajax, Barrie
2024-09-04
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Calgary, Edmonton, Red Deer, Vancouver, Moncton, St. John's, Hamilton, London
2024-05-20
Active, closed
Sanofi
Phase 3
1,541
Calgary, Edmonton, Red Deer, Kelowna, Surrey, Winnipeg, Ajax, London
2024-05-08
Active, closed
Pfizer
Phase 3
394
Calgary, Red Deer, Markham, Mississauga, Toronto, Québec
2024-01-19
Active, closed
Ipsen
Phase 3
759
Halifax, Montreal, Red Deer, Sarnia, Victoria
2023-10-12
Active, closed
Ipsen
Phase 3
751
Montreal, Red Deer, Sarnia
2023-09-29
Active, closed
AbbVie
Phase 3
1,328
Calgary, Edmonton, Red Deer, Surrey, Winnipeg, St. John's, Hamilton, London
2023-06-21
Recruiting
University of Calgary
Not applicable
9,500
Calgary, Edmonton, Lethbridge, Medicine Hat, Red Deer
2023-05-01
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Calgary, Edmonton, Red Deer, Kelowna, Vancouver, Moncton, Halifax, New Minas
2023-03-09
Active, closed
Sanofi
Phase 2/3
1,856
Calgary, Edmonton, Red Deer, Surrey, Winnipeg, Ajax, Barrie, Hamilton
2022-08-22
Active, closed
Identification and Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning Pathway
NCT04744298Acute Respiratory Distress Syndrome, Hypoxemic Respiratory Failure, ARDS, Human
University of Calgary
Not applicable
19,916
Calgary, Edmonton, Fort McMurray, Grande Prairie, Lethbridge, Medicine Hat, Red Deer, St. Albert
2021-04-01
Active, closed
Medicago
Phase 2/3
30,918
Red Deer, Halifax, Brampton, Guelph, Newmarket, Toronto, Lévis, Mirabel
2020-11-19
Active, closed
Sun Pharmaceutical Industries, Inc.
Phase 2/3
1,000
Calgary, Red Deer, Kelowna, Surrey, Winnipeg, Barrie, Etobicoke, Guelph
2019-04-04
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-canada/city/red-deer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,553 studies in total at the last sync on 10 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in Red Deer.

How many clinical trials are recruiting in Red Deer?

13 of the 33 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:20 UTC sync. A further 2 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Red Deer), 33 studies
PhaseStudiesRecruitingShare
Phase 3221066.7%
Not applicable329.1%
Phase 2319.1%
Phase 2/3309.1%
Observational103%
Phase 1/2103%

Most active sponsors

Lead sponsors with the most studies (Red Deer)
Lead sponsorStudiesRecruiting
Pfizer63
University of Calgary43
Ipsen30
Merz Therapeutics GmbH20
Novo Nordisk A/S21
Sanofi20
Sun Pharmaceutical Industries, Inc.21
AbbVie10
AbCellera Biologics Inc.10
Alumis Inc10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.